Exploring the mechanisms of clozapine-induced blood-brain barrier dysfunction using untargeted metabolomics and cellular metabolism analysis

Environ Toxicol Pharmacol. 2023 Sep:102:104219. doi: 10.1016/j.etap.2023.104219. Epub 2023 Jul 13.

Abstract

Brain microvascular endothelial cells (BMVECs) from the blood- brain barrier form a highly selective membrane that protects the brain from circulating blood and maintains a stable microenvironment for the central nervous system. BMVEC dysfunction has been implicated in a variety of neurological and psychiatric disorders. Clozapine, a widely used antipsychotics, has been demonstrated to alter the permeability of BMVECs, but the underlying mechanisms of this effect are not fully understood. In this study, we investigated the effects of clozapine in BMVECs using untargeted metabolomics analysis. Our results illustrated that treatment with clozapine led to significant changes in the metabolic profile of BMVECs, including alterations in amino acid and energy metabolism. These findings suggest that clozapine affects BMVEC permeability through its effects on cellular metabolism. Our study could inform the development of more targeted and effective treatments for understanding the relationships among clozapine, cellular metabolism, and BMVECs in more detail.

Keywords: Blood–brain barrier; Clozapine; Liquid chromatography-mass spectrometry; Microvascular endothelial cells; Untargeted metabolomics.

MeSH terms

  • Blood-Brain Barrier*
  • Brain
  • Clozapine* / metabolism
  • Clozapine* / toxicity
  • Endothelial Cells
  • Humans
  • Metabolomics

Substances

  • Clozapine